This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Christopher C. Fraser
Introduction
Christopher C. Fraser is a notable inventor based in Los Altos, California. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the production of human immune cells in chimeric immunocompromised mice, which has important implications for medical research and therapies.
Latest Patents
Christopher C. Fraser holds a patent titled "Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice." This patent describes a method where immunocompromised mammalian hosts are subcutaneously implanted with a combination of human fetal bone and spleen. The chimeric animals produced can generate human B-cells, myeloid cells, and T-cells for up to nine months in vivo when supplied with an allogeneic human fetal thymic fragment at the same site. The grafts contain cell populations expressing various markers, including CD4, CD8, CD19, CD33, CD14, and CD15, all of which express the HLA type of the fetal bone and spleen. T-cells derived from progenitors in the fetal bone and spleen include both mature single positive CD4+CD8−, CD8+CD4−, as well as a high percentage of immature double positive CD4+CD8+ populations. This patent highlights Fraser's innovative approach to advancing immunological research.
Career Highlights
Christopher C. Fraser is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis focuses on developing innovative solutions in the field of immunology. His research has the potential to pave the way for new treatments and therapies that can enhance the immune response in patients.
Collaborations
Fraser collaborates with Benjamin P. Chen, who is also involved in similar research areas. Their combined expertise contributes to the advancement of knowledge in immunology and the development of new therapeutic strategies.
Conclusion
Christopher C. Fraser's contributions to the field of immunology through his innovative patent and work at Novartis AG demonstrate his commitment to advancing medical research. His work has the potential to significantly impact the development of new therapies for immune-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile